BROWSE BY TAGS
» Current Events
» Molecular Diagnostics
Showing page 1 of 5 (46 total posts)
We’re all familiar with the popularity of crowdfunding
websites like Kickstarter for both the largely successful and also the somewhat
misguided attempts to gather funding for movies and music videos, but lately a much more serious group has
turned to crowdfunding: clinical researchers. In an effort to gain additional
funding for its handheld ...
The implementation of the Affordable Care Act, or ObamaCare,
has already seen several new laws and regulatory measures introduced since its
implementation, with many more soon to be on the horizon. One of these is the Sunshine
Act, a law requiring public disclosure of any financial agreements between
healthcare vendors and providers. Recent ...
The influence of genetic sequencing has left its mark across
the healthcare industry. In a recent partnership with Pennsylvania’s Geisinger
Health System, Regeneron Pharmiceuticals, who recently came out with Eylea for
age-related macular degeneration, is looking to take some of the the first
substantial steps in making that vision a reality. ...
The concept of genetic mosaics and chimeras in terms of our
individual genomes has come up before,
but continued research seems to be confirming the suspicion that there is no
one individual genome lately. As I discussed in the last article, “chimera” is
a term used to describe “a living thing with several populations of cells with
Digital technology is a factor that affects almost every
field across the country. Specifically, the implementation of digital
counterparts to traditional tests and assays in the clinical testing industry has
already started to leave a mark on the field. While the introduction of new
techniques is common in the evolving backdrop of the ...
In recent months, there has been a lot of litigation and
government influence regarding companies offering genetic sequencing services. Following
the memorable SCOTUS
ruling against Myriad Genetics in June and the company’s subsequent
law suit involving Ambry Genetics, the FDA joined in on further regulatory
disputes with a cease-and-desist ...
Every day, there are unprecedented advances in any number of
fields in the healthcare industry. As personalized treatments become the norm,
genetic sequencing options allow physicians to understand their patients at the
genetic level -- and what could be more personal than that? On top of this,
electronic health records (EHR) transfer specific ...
Molecular engineering has been a favorite topic for
socio-political science fiction writers all over the world. Similarly, the
concept of manipulating viruses to fight other infections or disease -- in this
case, cancers -- stretches even beyond the ideas of those authors into a whole
new territory of treatment options. According to a recent ...
Despite the comparatively small amount of information we
know about it, Parkinson’s disease is extremely common. A recent article from
Medical News Today noted that the neurological disorder affects over a million
people in the US and has developed a reputation as being difficult to diagnose.
Up until recently, the disease was only caught by ...
As personalized therapy becomes a more popular option for
patient treatment, the emergence of gene therapy seems like it was only a
matter of time. The idea of being able to diagnose and correct a medical
problem at the molecular level is exciting for researchers and physicians
alike, especially when it comes to rare diseases and disorders ...